Regenerative birth tissue products from amniotic and umbilical cord tissue
BioTissue develops regenerative healing products from human amniotic and umbilical cord tissue, a market it has served since 1997. Accelerating hiring tilts heavily toward senior sales talent, matching job-post themes of key account plans and new-customer acquisition. Behind that commercial push sits an Azure-centric IT stack with CrowdStrike and Palo Alto Networks, plus a sprawl of ERP systems (Sage X3, NetSuite, Epicor, Infor, Dynamics 365) that hints at consolidation pressure.
BioTissue is a privately held biotechnology company headquartered in Miami, Florida, producing therapies derived from human placental tissues, including amniotic membrane and umbilical cord. Founded in 1997, it has focused on bringing these tissues into clinical use, with its products documented across a substantial body of peer-reviewed research. The company spans biotechnology, medical device and pharmaceutical work. It employs 201–500 people, with hiring concentrated in the United States across sales, manufacturing, operations and healthcare functions.
BioTissue runs on Microsoft Azure (Virtual Machines, Files, Logic Apps, Monitor), secured by CrowdStrike and Palo Alto Networks, with Salesforce, Power BI, Slack, Smartsheet, and ERP tools like Sage X3, NetSuite and Dynamics 365.
Yes. Sales is BioTissue's dominant hiring area, weighted toward senior roles, with job posts focused on key account planning, territory business plans and winning new customers across the United States.
BioTissue is headquartered in Miami, Florida, and is a privately held company with 201–500 employees.
Other companies in the same industry, closest in size
BioTissue's technology stack, projects, and hiring signals are inferred from public hiring and company data — career pages, public listings, and company web presence — then clustered and de-duplicated. Figures are estimates that refresh over time. Read our full methodology →
This is not an official vendor or customer list. It is a technology-adoption signal inferred from public data, intended for B2B research.